Key facts
- This page summarizes Sid Sankaran's Form 4 filing for Oscar Health, Inc. (OSCR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Nov 2022, 15:13.
Sid Sankaran - 09 Nov 2022 Form 4 Insider Report for Oscar Health, Inc. (OSCR)
- Reporting relationship
- Director, Senior Advisor
- Issuer ticker
- OSCR
- Reported as of
- 09 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Nov 2022, 15:13:36 UTC
- Prior SEC filing
- 18 Apr 2022
- Next SEC filing
- 03 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa Curtin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sid Sankaran filed Form 4 for Oscar Health, Inc. (OSCR) on 14 Nov 2022.
Change
- Previous filing in this sequence was filed on 18 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OSCR
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +911,392
- Change %
- Price
- $0.000000
- Shares after
- 911,392
- Date
- 09 Nov 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 911,392
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
Footnote F2
The restricted stock units will vest in four equal quarterly installments over the one-year period beginning December 1, 2022.